Prostate Cancer

Targeted MRI Could Pinpoint Aggressive Prostate Cancers Before They Spread

The ZD2-Gd probe, represented by the orange ball and green arrow, binds to the EDB-FN in the prostate cancer cells with high metastatic potential. This results in a strong MRI signal (upper right). Prostate cancer cells with low metastatic potential have no EDB-FN and so there is no MRI signal (lower right). Credit: Han, et al., Bioconjug Chem-Apr-2017

News | Prostate Cancer | May 24, 2017

A research team funded by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) has engineered a...

FALCON Trial of Fluciclovine PET/CT Imaging Stops Recruitment after Successful Interim Analysis
News | Radiopharmaceuticals and Tracers | May 15, 2017

Blue Earth Diagnostics announced that the Trial Steering Committee recommended further recruitment be stopped in the...

News | Prostate Cancer | April 24, 2017

April 24, 2017 — Cancer Targeted Technology recently announced it is focusing on small molecules that target pivotal...

MRI

Multiparametric MRI (MpMRI) has proved helpful in enhancing biopsy sampling for prostate cancer when combined with ultrasound. 

Feature | Prostate Cancer | April 10, 2017 | By Jeff Zagoudis

While prostate cancer is one of the most common cancers among American men — the third leading cause of cancer...

News | Prostate Cancer | April 04, 2017

Profound Medical Corp. announced that the first TULSA-PRO patient paid procedure has been successfully conducted at...

Analogic, bkFusion, bk3000, MRI-ultrasound fusion, prostate biopsy, EAU 2017
News | Biopsy Systems | March 30, 2017

March 30, 2017 — Analogic Corp.

high-intensity focused ultrasound, HIFU, prostate tissue ablation, after radiotherapy, EDAP TMS SA, Ablatherm, British Journal of Urology International study
News | Focused Ultrasound Therapy | March 29, 2017

EDAP TMS SA announced the publication of a peer-reviewed article that analyzed Ablatherm Robotic HIFU (high-...

VERT, virtual environment radiotherapy, radiation therapy, patient anxiety, Thomas Jefferson University study
News | Radiation Therapy | March 27, 2017

March 27, 2017 — Radiation therapists and physicians know that education can reduce anxiety before radiation...

Karmanos Cancer Institute, UroNav Fusion Biopsy System, prostate cancer
News | Biopsy Systems | March 23, 2017

March 23, 2017 — Urology specialists at the Barbara Ann Karmanos Cancer Institute (Detroit) have begun using the...

News | Prostate Cancer | March 22, 2017

Profound Medical Corp. announced that it has successfully completed the first sale of a TULSA-PRO system in Finland...

Exact Imaging, Health Canada approval, ExactVu micro-ultrasound system, prostate biopsies, Sunnybrook Health Sciences Centre, Gregory Czarnota
News | Biopsy Systems | March 16, 2017

March 16, 2017 — Exact Imaging has received Health Canada approval and the corresponding medical device license (#...

PET/CT, recurrent prostate cancer, fluciclovine F-18, Emory University

CTVPOST (red) = CTVPRE (yellow) union CTVPET (pink). Also shown (upper right corner) are the PRE (square) vs POST (triangle) dose volume histograms for PTV1, PTV2, rectum, bladder, and penile bulb, showing minimal impact on target coverage or organs at risk dose with the modified targets. Image courtesy of Ashesh B. Jani, M.D., and David Schuster, M.D., Emory University.

News | Radiopharmaceuticals and Tracers | March 16, 2017

The featured clinical investigation article of the March 2017 issue of the Journal of Nuclear Medicine demonstrates...

Michigan Medicine, Prostate Cancer Risk Clinic, first in the U.S.
News | Prostate Cancer | March 09, 2017

Michigan Medicine and the University of Michigan have launched the nation’s first prostate cancer risk clinic,...

prostate cancer, radiation therapy, high-dose-rate brachytherapy, HDR, Red Journal study

This is a single-fraction high-dose-rate prostate implant imaging and dosimetry. Image courtesy of Daniel Krauss/American Society for Radiation Oncology (ASTRO)

News | Brachytherapy Systems | March 06, 2017

March 6, 2017 — Results from a new prospective clinical trial indicate high-dose-rate (HDR)...

ayDCE software, mpMRI, multiparametric magnetic resonance imaging, prostate MRI, RSNA 2017, AHRA, SIIM
Technology | Magnetic Resonance Imaging (MRI) | February 13, 2017

February 13, 2017 —  aycan recently introduced ayDCE software powered by aycan workstation.

Blue Earth Diagnostics, Axumin, fluciclovine F-18, recurrent prostate cancer, Simens PETNET Solutions, increased patient access
News | Radiopharmaceuticals and Tracers | February 07, 2017

Blue Earth Diagnostics and Siemens’ PETNET Solutions announced that an increasing number of radiopharmacies will...

recurrent prostate cancer, hormone therapy, radiation therapy, Cedars-Sinai study, New England Journal of Medicine
News | Prostate Cancer | February 03, 2017

Adding hormonal therapy to radiation treatment can significantly improve the average long-term survival of men with...

PET/CT, primary and metastatic prostate cancer, Journal of Nuclear Medicine study, JNM

Ga-68-BBN PET/CT of a 64-year-old man newly diagnosed with prostate cancer by biopsy. Multiple bone metastasis lesions (arrows) were detected. Image courtesy of Jingjing Zhang, Peking Union Medical College, Beijing, China.

News | Prostate Cancer | February 02, 2017

In the featured article from the February 2017 issue of the Journal of Nuclear Medicine, researchers document the...

prostate cancer, PI-RADS, best clinical research paper, European Urology
News | Prostate Cancer | January 18, 2017

An article promoting standardized imaging efforts to improve diagnosis and treatment of prostate cancer has been...

Overlay Init